A phase I study of capecitabine, cisplatin and imatinib in patients with unresectable or metastatic gastric cancer.

Trial Profile

A phase I study of capecitabine, cisplatin and imatinib in patients with unresectable or metastatic gastric cancer.

Completed
Phase of Trial: Phase I

Latest Information Update: 18 Mar 2013

At a glance

  • Drugs Capecitabine (Primary) ; Cisplatin (Primary) ; Imatinib (Primary)
  • Indications Gastric cancer
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 20 Jul 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 20 Jul 2011 Actual end date (Jan 2011 ) added as reported by ClinicalTrials.gov.
    • 18 Feb 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top